| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/10/2005 | WO2004092348A3 Method for production of oncolytic adenoviruses |
| 03/10/2005 | WO2004055161A3 Large scale production of packaged alphavirus replicons |
| 03/10/2005 | WO2004044182A3 Highly permissive cell lines for hepatitis c virus replication |
| 03/10/2005 | WO2004016732A3 Astrocyte modulated genes and uses thereof |
| 03/10/2005 | WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 03/10/2005 | US20050054846 Method for generating influenza viruses and vaccines |
| 03/10/2005 | US20050054107 Replicon particles comprising viral proteins for use in vaccines against viral disease; viricides |
| 03/10/2005 | US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics |
| 03/10/2005 | US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference |
| 03/10/2005 | US20050053920 Retrovirus from the HIV group and its use |
| 03/10/2005 | US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection |
| 03/10/2005 | US20050053624 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus |
| 03/10/2005 | US20050053620 Recombinant vaccinia virus vaccine |
| 03/10/2005 | US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
| 03/10/2005 | CA2536734A1 A rotavirus vaccine |
| 03/10/2005 | CA2532335A1 Functional influenza virus-like particles (vlps) |
| 03/09/2005 | EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof |
| 03/09/2005 | EP1512001A1 Methods and apparatus for harvesting vaccine from eggs |
| 03/09/2005 | EP1511864A2 Viral capsid assembly intermediates |
| 03/09/2005 | EP1511840A1 Process for preparing an adenovirus-containing preparation |
| 03/09/2005 | EP1511377A1 Sterilization, stabilization and preservation of functional biologics |
| 03/09/2005 | EP1233783B1 Hbv/hcv virus-like particle |
| 03/09/2005 | CN1592794A Cell culture system for synthesis of infectious hepatitis C virus |
| 03/09/2005 | CN1590552A Recombination VSV virus carrier and recombination VSV virus and its preparation method and use |
| 03/09/2005 | CN1590542A Aids recombination gland virus vaccine |
| 03/09/2005 | CN1192112C Mutant herpes simplex viruses and uses thereof |
| 03/08/2005 | US6864083 Expression vectors; use in identifying compound that modulates receptor activated calcium mobilization |
| 03/08/2005 | US6864082 Modified viral surface proteins for binding to extracellular matrix components |
| 03/03/2005 | WO2005019470A2 Detecting and profiling molecular complexes |
| 03/03/2005 | WO2004104032A3 Methods and compositions related to high-titer pseudotyped retroviruses |
| 03/03/2005 | WO2004025256A3 Viral deconstruction through capsid assembly in vitro |
| 03/03/2005 | WO2004000876A8 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS |
| 03/03/2005 | US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics |
| 03/03/2005 | US20050048466 Recombinant virus comprising virus proliferating essential gene (VPEG) for use in the treatment of cell proliferative disorders; cancer therapeutics |
| 03/03/2005 | US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/03/2005 | US20050048030 Parainfluenza virus, respiratory syncytial virus infection genetic engineering vectors; heterologous nucleic acids |
| 03/03/2005 | CA2816222A1 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2005 | CA2535510A1 Detecting and profiling molecular complexes |
| 03/03/2005 | CA2529647A1 Influenza hemagglutinin and neuraminidase variants |
| 03/02/2005 | EP1510130A1 Virus inactivating agent and virus inactivating method, filter set having the inactivating agent, and air conditioner equipped with the filter set |
| 03/02/2005 | EP1198475B1 Highly purified cytokine activating factor and methods of use |
| 03/02/2005 | EP1140974B1 Neutralizing assay using human papillomavirus virus-like particles |
| 03/02/2005 | EP1137764B1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 03/02/2005 | EP0977881B1 Expression of a modified foamy virus envelope protein |
| 03/02/2005 | EP0846181B1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191094C Targeted liposome gene delivery |
| 03/02/2005 | CN1191092C Multivaleng dengue virus vaccine |
| 03/01/2005 | US6861001 Passing a sample through a membrane grafted with a polymer having functional groups interactive with the viruses and with a pore size of 20-1000nm; cleaning blood of infection gene therapy; genetic engineerng; nonremoval of proteins |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 02/24/2005 | WO2005017208A1 Compositions and methods for treating or preventing hiv infection |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2004085634A3 Infectious bursal disease virus mutants and vaccines |
| 02/24/2005 | WO2004052274A3 Production of bacteriophage compositions for use in phage therapy |
| 02/24/2005 | WO2003061582A3 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 02/24/2005 | US20050042740 Using ligand conjugated matrix to isolate functional adenoassociated viral particles from solution |
| 02/24/2005 | US20050042716 Allergen inactivating method, allergen inactivating filter, air treating apparatus, virus inactivating agent, virus inactivating method, virus inactivating filter, air conditoning unit and air conditioner |
| 02/24/2005 | US20050042659 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 02/24/2005 | US20050042603 Protein fusion comprising nuclear localization signal domain for use as tool to enhance gene transfer into cells: gene therapy and heterologous gene expression |
| 02/24/2005 | US20050042234 Method |
| 02/24/2005 | US20050042206 Viral vectors having reduced virulence |
| 02/24/2005 | DE20122302U1 Variante des Modifizierten Vaccinia-Ankara-Virus Modified version of the vaccinia Ankara virus |
| 02/24/2005 | CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/23/2005 | EP1508615A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/23/2005 | EP1507851A1 Method for assembling sub units into capsoides |
| 02/23/2005 | CN1584028A Cloning for sifting tumor hecrosis target antibody, preparing method and use thereof |
| 02/23/2005 | CN1584022A Virus inactivating agent, virus inactivating method, filter with the virus inactivating and air conditioner therewith |
| 02/23/2005 | CN1584021A Collecting method for insect virus breed |
| 02/22/2005 | US6858590 With an antigen that has an epitope of hepatitis c virus |
| 02/17/2005 | WO2005014836A2 Chimaeric vector system |
| 02/17/2005 | WO2005014803A1 West nile virus vaccine |
| 02/17/2005 | WO2005014626A2 Recombinant human metapneumovirus and its use |
| 02/17/2005 | WO2005013918A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/17/2005 | WO2004083397A3 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 02/17/2005 | WO2004000872A3 Improved alphavirus vectors having attenuated virion structural proteins |
| 02/17/2005 | WO2003101396A3 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | US20050038238 Using triplex formation as a tool in prevention of viral gene expression; viricides |
| 02/17/2005 | US20050037487 Recombinant influenza vectors with a PolII promoter and ribozymes for vaccines and gene therapy |
| 02/17/2005 | US20050037479 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037016 determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse; the antibody binds to MNV-1 deposited as American Type Culture Collection (ATCC) Deposit No. PTA-5935 or to a polypeptide encoded by it |
| 02/17/2005 | CA2807534A1 Methods of producing influenza vaccine compositions |
| 02/17/2005 | CA2678736A1 Novel multifunctional il-2 - il-18 fusion proteins |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2517394A1 Recombinant human metapneumovirus and its use |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506287A2 Methods of adenovirus purification |
| 02/16/2005 | EP1506021A2 Novel use of adenoviruses and nucleic acids coding therefor |
| 02/16/2005 | EP1093524B1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 02/16/2005 | EP0846160B1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 02/16/2005 | CN1582333A Live vaccine and method of manufacture |
| 02/16/2005 | CN1582164A Antigen arrays for treatment of bone disease |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/15/2005 | US6855535 Comprises serum-free culture; protease-free |
| 02/15/2005 | US6855534 Enhanced system for construction of adenovirus vectors |
| 02/15/2005 | US6855529 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 02/15/2005 | US6855519 Methods for enhancing the production of interferon in cell culture |
| 02/15/2005 | US6855489 Systems and methods for removing viral agents from blood |